Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thiago Lisboa

Showing results (11-20 of 102) with videos related to

Pageof 11
Sort By:
Intensive Care Medicine|May 17, 2018
Caution for chlorhexidine gluconate use for oral care: insufficient dataJean-Damien Ricard, Thiago Lisboa
Critical Care Medicine|December 18, 2010
We should be measuring genomic bacterial load and virulence factorsThiago Lisboa, Grant Waterer, Jordi Rello
Intensive Care Medicine|November 14, 2015
Understanding why resistant bacteria are associated with higher mortality in ICU patientsFrançois Barbier, Thiago Lisboa, Saad Nseir
Intensive Care Medicine|October 23, 2013
Risk factors for Pseudomonas aeruginosa pneumonia in the early twenty-first centuryJordi Rello, Bárbara Borgatta, Thiago Lisboa
Intensive Care Medicine|July 16, 2018
The gut microbiota of critically ill patients: first steps in an unexplored worldÉtienne Ruppé, Thiago Lisboa, François Barbier
Critical Care (London, England)|January 28, 2018
Do we need new trials of procalcitonin-guided antibiotic therapy?Thiago Lisboa, Jorge Salluh, Pedro Povoa
Archivos De Bronconeumologia|April 1, 2010
[Pandemic influenza A (H1N1)v in the intensive care unit: what have we learned?]Alejandro Rodríguez, Thiago Lisboa, Jordi Rello, et al.
Critical Care (London, England)|September 30, 2011
C-reactive protein in community-acquired sepsis: you can teach new tricks to an old dogJorge I F Salluh, Thiago Lisboa
Current Infectious Disease Reports|August 25, 2009
Severe community-acquired pneumonia and PIRO: a new paradigm of managementJordi Rello, Thiago Lisboa, Richard Wunderink
The Lancet. Respiratory Medicine|August 25, 2014
Respiratory infections in patients undergoing mechanical ventilationJordi Rello, Thiago Lisboa, Despoina Koulenti
Pageof 11

Showing results (11-20 of 102) with videos related to

Sort By:
Pageof 11
Intensive Care Medicine|May 17, 2018
Caution for chlorhexidine gluconate use for oral care: insufficient dataJean-Damien Ricard, Thiago Lisboa
Critical Care Medicine|December 18, 2010
We should be measuring genomic bacterial load and virulence factorsThiago Lisboa, Grant Waterer, Jordi Rello
Intensive Care Medicine|November 14, 2015
Understanding why resistant bacteria are associated with higher mortality in ICU patientsFrançois Barbier, Thiago Lisboa, Saad Nseir
Intensive Care Medicine|October 23, 2013
Risk factors for Pseudomonas aeruginosa pneumonia in the early twenty-first centuryJordi Rello, Bárbara Borgatta, Thiago Lisboa
Intensive Care Medicine|July 16, 2018
The gut microbiota of critically ill patients: first steps in an unexplored worldÉtienne Ruppé, Thiago Lisboa, François Barbier
Critical Care (London, England)|January 28, 2018
Do we need new trials of procalcitonin-guided antibiotic therapy?Thiago Lisboa, Jorge Salluh, Pedro Povoa
Archivos De Bronconeumologia|April 1, 2010
[Pandemic influenza A (H1N1)v in the intensive care unit: what have we learned?]Alejandro Rodríguez, Thiago Lisboa, Jordi Rello, et al.
Critical Care (London, England)|September 30, 2011
C-reactive protein in community-acquired sepsis: you can teach new tricks to an old dogJorge I F Salluh, Thiago Lisboa
Current Infectious Disease Reports|August 25, 2009
Severe community-acquired pneumonia and PIRO: a new paradigm of managementJordi Rello, Thiago Lisboa, Richard Wunderink
The Lancet. Respiratory Medicine|August 25, 2014
Respiratory infections in patients undergoing mechanical ventilationJordi Rello, Thiago Lisboa, Despoina Koulenti
Pageof 11